Severe Acute Respiratory Syndrome
"Severe Acute Respiratory Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.
| Descriptor ID |
D045169
|
| MeSH Number(s) |
C02.782.600.550.200.750 C08.730.730
|
| Concept/Terms |
Severe Acute Respiratory Syndrome- Severe Acute Respiratory Syndrome
- Respiratory Syndrome, Severe Acute
- SARS (Severe Acute Respiratory Syndrome)
- Respiratory Syndrome, Acute, Severe
|
Below are MeSH descriptors whose meaning is more general than "Severe Acute Respiratory Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Severe Acute Respiratory Syndrome".
This graph shows the total number of publications written about "Severe Acute Respiratory Syndrome" by people in this website by year, and whether "Severe Acute Respiratory Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 10 | 1 | 11 |
| 2004 | 8 | 0 | 8 |
| 2005 | 11 | 2 | 13 |
| 2006 | 2 | 3 | 5 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 1 | 3 |
| 2012 | 2 | 0 | 2 |
| 2014 | 2 | 0 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2020 | 4 | 5 | 9 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Severe Acute Respiratory Syndrome" by people in Profiles.
-
Misleading nomenclature of units of WHO materials used for standardization of SARS COv-2 serology. Clin Chem Lab Med. 2022 06 27; 60(7):e151-e152.
-
An efficient chemical screening method for structure-based inhibitors to nucleic acid enzymes targeting the DNA repair-replication interface and SARS CoV-2. Methods Enzymol. 2021; 661:407-431.
-
Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-A Territory-Wide Cohort Study. Clin Infect Dis. 2021 05 18; 72(10):e466-e475.
-
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols. Elife. 2021 04 16; 10.
-
Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets. Int J Mol Sci. 2020 Oct 29; 21(21).
-
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021 03; 18(3):169-193.
-
COVID-19 and Cardiovascular Health Among Patients with Cancer. Curr Cardiol Rep. 2020 10 10; 22(12):171.
-
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices. Hypertension. 2020 11; 76(5):1350-1367.
-
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement. Vaccine. 2020 11 03; 38(47):7533-7541.
-
Reentry Reflections: Views on COVID-19 From a Global Health Trainee. Pediatrics. 2020 09; 146(3).